Altimeter Capital Management LP acquired a new position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 3rd quarter, Holdings Channel reports. The firm acquired 258,280 shares of the semiconductor company’s stock, valued at approximately $127,433,000. Synopsys comprises approximately 1.7% of Altimeter Capital Management LP’s holdings, making the stock its 16th biggest holding.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. boosted its position in Synopsys by 20.7% during the 3rd quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock worth $8,970,415,000 after purchasing an additional 3,120,401 shares during the period. State Street Corp raised its position in Synopsys by 1.2% in the second quarter. State Street Corp now owns 7,266,446 shares of the semiconductor company’s stock valued at $3,725,362,000 after purchasing an additional 85,662 shares during the period. Victory Capital Management Inc. lifted its stake in shares of Synopsys by 238.8% during the third quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company’s stock worth $1,393,506,000 after purchasing an additional 1,990,608 shares in the last quarter. Ameriprise Financial Inc. lifted its stake in shares of Synopsys by 29.1% during the second quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock worth $1,333,095,000 after purchasing an additional 585,494 shares in the last quarter. Finally, Capital Research Global Investors boosted its position in shares of Synopsys by 226.6% in the third quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company’s stock worth $1,245,533,000 after buying an additional 1,751,432 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Trading Down 1.5%
Shares of SNPS opened at $412.63 on Friday. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The stock has a 50-day moving average price of $461.93 and a 200 day moving average price of $463.65. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.26 and a current ratio of 1.36. The company has a market capitalization of $79.04 billion, a P/E ratio of 64.07, a P/E/G ratio of 3.36 and a beta of 1.15.
Insiders Place Their Bets
In related news, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares in the company, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Janet Lee sold 250 shares of the company’s stock in a transaction on Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares in the company, valued at $6,338,270. This represents a 2.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 4,157 shares of company stock valued at $1,945,036. Insiders own 0.56% of the company’s stock.
Analysts Set New Price Targets
A number of research firms have recently issued reports on SNPS. Needham & Company LLC reiterated a “buy” rating on shares of Synopsys in a research note on Thursday, February 26th. Morgan Stanley reissued an “equal weight” rating and set a $480.00 price target (down from $550.00) on shares of Synopsys in a research report on Wednesday, February 25th. Wells Fargo & Company lowered their price objective on shares of Synopsys from $500.00 to $450.00 and set an “equal weight” rating for the company in a research report on Thursday, February 26th. Piper Sandler dropped their price objective on shares of Synopsys from $520.00 to $430.00 and set a “neutral” rating on the stock in a research note on Thursday, February 26th. Finally, Wall Street Zen raised shares of Synopsys from a “sell” rating to a “hold” rating in a research report on Saturday, December 13th. Eight analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $531.00.
Get Our Latest Report on Synopsys
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- A personal warning from Martin Weiss (Please read)
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
